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Deutsche Zusammenfassung 
 
1. Deutsche Zusammenfassung 
Die Prävalenz von Adipositas wird derzeitig, mit steigender Tendenz, auf circa 
300 Millionen Menschen weltweit geschätzt. Nach dem gegenwärtigen 
wissenschaftlichen Kenntnisstand wird Adipositas als eine komplexe und  
multifaktorielle Erkrankung verstanden. Aus diesem Grund ist es in 
Adipositasstudien erforderlich, umfassende und weit reichende 
Messparameter und Studienendpunkte zu verwenden, um einerseits die 
Krankheitslast in ihrem gesamten Umfang zu erfassen und andererseits die 
Behandlungsergebnisse besser beurteilen zu können. 
Eine genaue Untersuchung von Adipositasstudien der letzten zehn Jahre kann 
bei der Definition einer Vorgabe mithelfen, welche Messparameter 
grundsätzlich in Adipositasstudien verwendet werden sollten. Diese Vorgabe 
muss die für Adipositaspatienten spezifische Krankheitslast umfassend 
beschreiben. Durch die universelle Verwendung dieser Vorgabe kann in 
Zukunft das Auswerten und Vergleichen der Behandlungsergebnisse  von 
Adipositasstudien vereinfacht werden.  
Seitdem die  Internationale Klassifikation der Funktionsfähigkeit, Behinderung 
und Gesundheit (ICF) von der Weltgesundheitsorganisation im Mai 2001 als 
einheitliche Sprache eingeführt wurde, ist es möglich Konzepte die in 
Messergebnissen  beinhaltet sind zu identifizieren und zu vergleichen. 
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Ziel dieser Arbeit ist die systematische Identifizierung von Konzepten die in 
Messparametern klinischer Adipositasstudien der Jahre 1992 bis 2001 
enthalten sind. Die identifizierten Konzepte werden dabei in das 
Ordnungssystem der ICF  übersetzt („linking“) und so bestimmten ICF-
Kategorien zugeordnet. Des Weiteren wird in dieser Arbeit die Verwendung 
von adipositasspezifischen, generischen und dimensionsspezifischen Health-
Status Fragebögen untersucht. Die Konzepte der in den Studien verwendeten 
Fragebögen werden dabei ebenso in das Ordnungssystem der ICF übersetzt 
(„linking“). 
 
Ein systematischer Literaturreview wurde durchgeführt, um randomisierte 
kontrollierte Studien (RCTs) mit Adipositaspatienten zu lokalisieren und zu 
selektieren. Alle Verfahren zur Outcome-Erfassung in den ausgewählten RCTs 
wurden identifiziert. Die Inhalte dieser Messverfahren wurden anschließend 
untersucht, indem sie mit Hilfe der sogenannten Linking Methode zur ICF in 
Verbindung gesetzt wurden.  
 
Insgesamt wurden 428 Studien mit Adipositaspatienten in den Literaturreview 
eingeschlossen. Es wurden 57 verschiedene Health-Status Fragebögen in den 
ausgewerteten Publikationen verwendet. Aus den 428 Studien wurden 16 034 
Konzepte identifiziert, davon konnten 81% dem Kategoriensystem der ICF 
zugeordnet werden. Die am häufigsten verwendeten ICF-Kategorien, aufgeteilt  
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nach deren ICF-Klassifikationskomponente Körperfunktionen, Aktivität und 
Partizipation, Umweltfaktoren und Körperstrukturen, waren `Allgemeine 
Stoffwechselfunktionen´ (b540), `Sorge um die eigene Gesundheit´ (d570), 
`Produkte oder Substanzen für den persönlichen Konsum´ (e110) und 
`Struktur des Rumpfes´ (s760) mit den jeweils folgenden Häufigkeiten von 
65%, 57%, 16% und 13%. 
 
Diese Studie zeigt, daß die ICF ein nützliches Referenzsystem  zur 
Identifizierung und Quantifizierung von Konzepten aus Verfahren zur 
Erfassung der Studienendpunkte in Adipositasstudien ist. Es scheint ein 
Mangel an ICF-Kategorien der ICF-Klassifikationskomponente 
Körperstrukturen in klinischen Adipositasstudien vorzuliegen. Außerdem 
besteht die Notwendigkeit patientenorientierte Messergebnisse, aus der für 
Adipositaspatienten stark relevanten ICF-Klassifikationskomponente Aktivität 
und Partizipation, vermehrt in Adipositasstudien einzuschließen. 
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Abstract 
 
2. Abstract 
The prevalence of obesity is currently estimated at about 300 million people 
worldwide and is rising further on. Based on the current understanding of 
obesity as a complex, multifactorial condition, comprehensive outcomes are 
necessary for both the measurement of the burden of disease and the 
evaluation of treatment outcomes. An in-depth understanding of the outcome 
domains that have been used in studies of obesity in the last decade can bring 
us one step ahead in the definition of a set of domains that define “what should 
be measured” to comprehensively describe the burden of obesity and/or the 
evaluation of treatment outcomes.  
Using the new International Classification of Functioning, Disability and Health 
(ICF), which was endorsed by the Word Health Assembly in May 2001 as a 
reference or common language, it is now possible to identify and compare the 
concepts contained in different outcome measures. 
 
Objective The objective of this doctoral thesis was to examine the use of 
concepts contained in outcome measures of randomized controlled obesity 
trials (RCTs) between 1992 und 2001, using the ICF as a reference tool.  
This doctoral thesis also examines the use of the obesity-specific, generic and 
dimension-specific health status measures and concepts contained in these 
measures using the ICF as a reference tool.  
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Methods: Randomized controlled trials between 1992 and 2001 were located 
in MEDLINE and selected according to predefined criteria. The outcome 
measures were extracted and the concepts contained in the outcome 
measures were linked to the ICF.  
 
Results: A total of 428 trials were included in the study. Fifty-seven different 
health status questionnaires were extracted. Of 16 034 extracted concepts 
81% could be linked to the ICF. The most used ICF categories within the 
components body functions, activities and participation, environmental factors 
and body structures, were general metabolic functions (b540), looking after 
one’s health (d570) products or substances for personal consumption (e110) 
and structure of the trunk (s760) with frequencies of 65%, 57%, 16% and 13% 
respectively. 
 
Conclusion: The ICF provides a useful reference to identify and quantify the 
concepts contained in outcome assessment used in clinical obesity trials. 
There seems to be a lack of health concepts evaluating specific aspects of 
body structures in obesity. Similarly, environmental factors with an impact on 
individual life on obesity patients seem to be poorly represented. The need 
exists to systematically include patient-oriented measures to address areas of  
the ICF component activities and participation that are extremely relevant to 
obese persons. 
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3. Introduction 
 
The prevalence of obesity is currently estimated at about 300 million 
people worldwide (WHO 2002) and is rising (Freedman 2002 , Ogden 2002). 
Allusions to obesity as an epidemic or even pandemic health condition are 
common in both scientific and non-scientific literature (Abelson 2004, Curtis 
2004, Aronne 2002). It is an exploding health issue in Europe and the United 
States, but it is not limited to the developed world: Mayans in Guatemala, 
South Africans, aboriginal Australians, and Pacific Islanders also show 
patterns of emerging obesity (Abelson 2004). 
Obesity is a major risk factor for premature mortality in relation to fatal 
cardiovascular diseases, certain cancers, and other medical conditions 
(Mokdad 2004, Flegal 2004, Manson 2004, Calle 2003). In a recent estimate 
of death attributable to obesity in the United States, obesity was the second 
leading modifiable factor, after smoking, contributing to death in 2000 (Mokdad 
2004). However, mortality is only a small part of the substantial burden of 
disease caused by obesity-related conditions (Manson 2003). 
Besides the overwhelming direct and indirect health-care costs (Colditz 
1999, Wolf 2002) due to obesity, it is already considered to be the fifth most 
serious risk factor for disease burden measured in disability-adjusted life years 
(DALYs) in developed and low-mortality developing countries (Peeters 2004). 
Moreover, at the individual level, obesity is associated with a decreased health 
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related quality of life (HRQOL) (Seidell 1995, Larsson 2002, Fontaine 1996, 
Fine 1999, Mathus-Vliegen 2004).  
Based on the current understanding of obesity as a complex, 
multifactorial condition with interactions among genetic, metabolic, 
environmental, and personal factors (National Institute of Health 2000), 
comprehensive evaluation is necessary for both the measurement of disease 
burden and the assessment of treatment outcomes. The currently available 
outcome measures have been reviewed by a task force of the North American 
Association for the Study of Obesity (NAASO) (Wolf 2002). Outcome 
measures that can be used to assess the effectiveness of treatment are 
outlined, and outcome measures to address clinical, HRQOL, and economic 
endpoints, as well as habits regarding dietary intake and physical activity, are 
differentiated [Task Force on Developing Obesity Outcomes and Learning 
Standards (TOOLS), 2002]. 
Different from other conditions, instruments to measure obesity-specific 
health status have only recently been developed (Kolotkin 1997). New 
versions of existing instruments are continuously being developed with respect 
to their contents and psychometric properties. Therefore, any recommendation 
regarding a specific instrument is likely to soon be outdated.  
To avoid this problem, at least to some extent, it would be preferable to 
first define “what should be measured” and only then to recommend how to  
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measure it or which instrument to use. This approach has already been 
successfully applied in rheumatology by the OMERACT group (Boers 1994). 
There are different approaches to develop a set of domains that define “what 
should be measured” to comprehensively describe the burden of a determined 
disease and/or the evaluation of treatment outcomes.  
An in-depth understanding of the outcomes that have been used in 
studies of obesity in the last decade brings us one step further in this respect. 
Such knowledge requires not only a review of the clinical endpoints, the 
obesity-specific, generic and dimension-specific health-status instruments 
used, but, more specifically, a review of the concepts covered by the items in 
the measuring instruments and a review of other outcome measures, including 
clinical and laboratory tests. Using the new International Classification of 
Functioning, Disability and Health (ICF), which was endorsed by the Word 
Health Assembly in May 2001 as a reference or common language, it is now 
possible to identify, quantify and compare the concepts contained in different 
outcome evaluations (Cieza 2002). 
The ICF is based on the integrative bio-psycho-social model of 
functioning, disability and health of the World Health Organization (WHO).  
The components of this model, as well as the understanding of their 
interactions, can be seen in Figure 1. 
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Figure 1: Biopsychosocial model of functioning, disability and health.  
 
Health condition 
(disorder or disease) 
Body Functions 
and Structures Activities Participation 
Enviromental 
Factors 
Personal 
Factors 
 
 
A health condition is an umbrella term for disease, disorder, injury or trauma 
and may also include other circumstances, such as ageing, stress, congenital 
anomaly, or genetic predisposition. It may also include information about 
pathogeneses and/or etiology. Interactions between the health condition and 
all components of functioning (body functions and structures, activity and 
participation) may exist.  
Body functions are defined as the physiological functions of body systems, 
including psychological functions. Body structures are the anatomical parts of 
the body, such as organs, limbs and their components. Abnormalities of 
function, as well as abnormalities of structure, are referred to as impairments, 
which are defined as a significant deviation or loss (e.g. deformity) of 
structures (e.g. joints) and/or functions [e.g. reduced range of motion (ROM), 
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muscle weakness, pain and fatigue]. 
Activity is the execution of a task or action by an individual and represents the 
individual perspective of functioning. Participation refers to the involvement of 
an individual in a life situation and represents the societal perspective of 
functioning. Difficulties at the activity level are referred to as activity limitation 
(e.g. limitations in mobility such as walking, climbing steps, grasping or 
carrying). Problems an individual may experience in his/her involvement in life 
situations are denoted as participation restriction (e.g. restrictions in 
community life, recreation and leisure, but also in walking, if walking is an 
aspect of participation in terms of a life situation). 
Contextual factors represent the entire background of an individual’s life and 
living situation. Within the contextual factors, the environmental factors make 
up the physical, social and attitudinal environment in which people live and 
conduct their lives. These factors are external to individuals and can have a 
positive or negative influence, i.e., they can represent a facilitator or a barrier 
for the individual.  
Personal factors are the particular background of an individual’s life and living 
situation and comprise features that are not part of a health condition, i.e. 
gender, age, race, fitness, life-style, habits and social background. They can 
be referred to as those factors which define the person as a unique individual. 
Personal factors cannot be impaired, limited or restricted. They can, however,  
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have a positive or negative impact on disability and functioning, i.e., on 
(impaired) body functions and structures, on (limited) activities and (restricted) 
participation. 
Since this bio-psycho-social view guided the development of the ICF, the 
components of the model correspond to the components of the classification. 
Within each component, there is a very exhaustive list of so-called ICF 
categories, which are the units of the classification. The ICF categories are 
hierarchically organized and are denoted by unique alphanumeric codes (see 
Figure 2). The categories are arranged in a stem/branch/leaf scheme within 
each component.  
Each component consists of chapters (first level). Each chapter consists of 
second-level categories, which, in turn, are composed of categories at the third 
level, which include fourth-level categories. An example from the component 
Body Functions is presented bellow: 
b2 Sensory functions and pain (first/ chapter level) 
b280 Sensation of pain (second level) 
b2801 Pain in body part (third level) 
b28013 Pain in back (fourth level). 
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Figure 2: The different levels of the ICF. The ICF uses an alphanumeric 
system in which letters b, s, d and e are used to denote body functions, body 
structures, activities and participation, and environmental factors, respectively. 
These letters are followed by a numeric code that starts with a chapter number 
(one digit), followed by a second level (two digit), and third and forth levels 
(one digit for each).  
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4. Methods 
 
4.1 Design 
A systematic review was performed in the following three steps: step 1, 
selection of studies, step 2, outcome measures extraction and step 3, linkage 
of the concepts contained in these outcomes measures to the corresponding 
categories in the ICF. 
 
4.1.1 Step 1: Selection of Studies 
RCTs between the years 1992-2001 were located in MEDLINE®, Silver 
Platter, 2000 Edition, by using Dickersin’s et al. (Dickersin 1994) highly precise 
search strategy (sets 1-8). Thereafter, the Dickersin search was combined with 
the obesity-specific search strategy using the ‘and’ operator. The explode-
function obesity-morbid, including the subheadings terms obesity, obese, 
overweight, were combined using the ‘or’ operator. All searches were limited to 
English articles. The search strategy is described in Figure 3. 
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Figure 3: Obesity-specific search strategy 
#1 randomized-controlled-trial in pt 
#2 randomized-controlled-trials 
#3 random-allocation 
#4 double-blind-method 
#5 single-blind-method 
#6 #1 or #2 or #3 or #4 or #5 
#7  (TG=animal) not ((TG=human) and (TG= animal)) 
#8 #6 not #7 
#9 obesity 
#10 obese 
#11 overweight 
#12 #9 or #10 or #11 
#13 English in la 
#14 (#8 and #12 and #13) not (py=1989-1991) 
#15 "Obesity-in-Diabetes"/ all subheadings 
#16 #14 not #15 
 
The abstracts were checked applying general and obesity-specific 
eligibility criteria. For the selected trials, the original study reports were ordered 
and reviewed again applying the same eligibility criteria. The studies finally 
included entered step 2 of the review.  
A study met general eligibility, if the study design was a RCT, the 
experimental intervention had a therapeutic aim, the outcomes measures were 
evaluated on patients, and if none of the following exclusion criteria were 
fulfilled: reviews, secondary analyses, psychometric studies, primary 
prevention studies (healthy population at risk), mode-of-action studies, and 
studies with mixed populations. In the presence of multiple publications on one 
study, the paper with the highest impact factor was included. 
To identify the appropriate study population in each health condition, 
condition-specific eligibility criteria were applied. To be included, the study had  
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to report the diagnosis of obesity to describe the study population. Studies on 
populations with coronary heart disease, stroke, osteoarthritis, and diabetes 
mellitus Types I and II were excluded. 
A detailed overview with the inclusion and exclusion criteria is shown in table 
1. 
 
4.1.2 Step 2: Outcome Measures Extraction 
In step 2, the “study characteristics” and all types of outcome measures were 
extracted and documented. The study characteristics included the variables 
regarding the description of the study population (age, body mass index, lean 
body mass index, blood pressure, disease duration, weight, recruitment 
pathway, e.g., inpatient care, specially care, primary care, occupational care, 
advertisement), the intervention type (e.g. nutritional therapy), the specific 
intervention (e.g. low-calorie diet), the number of treatment groups and the 
number of patients included in each treatment group. All types of outcome 
measures including clinical, biochemical, physiologic, and imaging tests, 
biopsies, one single item measures on different domains as well as 
questionnaires were extracted. If the items of a questionnaire were not 
specified in the publication, we attempted to obtain the questionnaire by 
reference checking, searches in databases or books on health status 
measures (Mc Dowell 1996, Bowling 1995), email-consultation with the 
developers of the questionnaire in demand, and internet searches, and then  
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the items were extracted. Only questionnaires available in English language 
were included. 
 
4.1.3 Step 3: Linkage of the Concepts 
In step 3, the concepts contained in the items of the identified 
questionnaires were identified and linked to the most specific ICF category by  
two independent health professionals according to a recently developed set of 
10 linking rules (Cieza 2002). In the case of the clinical, biochemical, 
physiologic, imaging tests and biopsies, the goal (e.g. carbohydrate 
metabolism) with which they had been performed was documented and linked 
to the ICF also by two independent health professionals applying the same 10 
linking rules. Consensus between health professionals was used to decide 
which ICF category should be linked. To resolve disagreements between the 
two health professionals concerning the selected categories, a third person 
trained in the linking rules and in the ICF was consulted. In a discussion led by 
the third person, the two health professionals stated their pros and cons for the 
selection of a specific ICF category. Based on these statements, the third 
person made an informed decision.  
Concepts or identified goals of outcome measures that could not be linked to 
the ICF were documented and classified in two ways: If a concept or the 
identified goal of an outcome measure was not sufficiently specified to make a  
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decision about which ICF-category the concept should be linked to, the ‘not 
definable’ option was chosen (linking rule 9). To give an example, unspecified 
concepts such as ‘functional status’, ‘health’, ‘disability’ or ‘symptoms’ were 
considered not to be definable for linking. If a concept of an outcome measure 
was not represented by the ICF, the option ‘not covered’ was chosen (linking 
rule 10). To give an example, concepts such as ‘plans about committing 
suicide’, ‘killing’ extracted from the BDI (Beck Depression Inventory) (Beck 
1961) were considered not to be covered by the ICF. 
 
4.2 Analyses 
Descriptive statistics were used to examine the frequency of ICF 
categories linked to the concepts and to the goals identified in the outcome 
measures. Large-scale cross tables generated from an SQL database (SQL 
Server 2000) were analyzed. If one and the same ICF category was assigned 
repeatedly in a study, the category was counted only once. 
The ICF is organized in a hierarchical scheme so that the more specific, lower-
level categories share the attributes of the less specific, higher-level category 
(WHO 2001). Only ICF categories with a percentage >10% at the 2nd level of 
the classification are shown (preset frequency). 
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5. Results 
 
5.1 Step 1: Selection of the Studies 
In step 1, 1382 trials were located by the search strategy. 519 studies 
were preliminarily selected by abstract checking, and 428 studies fulfilled the 
eligibility criteria by screening the respective original papers.  
 
5.2 Step 2: Outcome Measure Extraction  
In step 2, 9 different intervention types were identified in the 428 
analysed studies: Nutritional therapy (55.6%), drug therapy (54,0%), active 
physical therapy (22,0%), psychological intervention (20,6%), education 
(18,0%), surgery (5,4%), complementary medicine (0,9%), standard medical 
care (0,5%) and passive physical therapy (0,2%).  
201 studies examined the efficacy of one intervention (most often drug therapy 
with n= 103, nutritional therapy with n= 46, surgery with n= 19 and 
psychological intervention with n=13). 142 studies examined the efficacy of 
two interventions (including most often nutritional therapy with n= 112, drug 
therapy with n= 84, active physical therapy with n= 36, psychological 
intervention with n= 27 and education with n=21). The combination of 
nutritional therapy and drug therapy was used in 64 studies. 68 studies 
examined the efficacy of three interventions (involving most often nutritional 
therapy with n= 65, education with n=38, active physical therapy with n=35  
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psychological intervention with n=34 and drug therapy with n= 31). 14 studies 
examined 4 interventions (involving most often nutritional therapy with n= 14, 
education with n=13, psychological intervention with n= 12 and drug therapy 
with n= 8). Three studies examined the efficacy of five interventions. 
96 different questionnaires were identified. 39 questionnaires were not 
available in English or no references for them were listed in the original 
literature and therefore they could not be identified. Thus, only 57 of the 96 
questionnaires were linked to the ICF. Table 2 shows the questionnaires that 
were used in more than 2 studies, the number of studies in which they were 
used and the type of instrument (condition specific, dimension specific, eating 
disorder specific, generic or obesity specific). At least one health status 
questionnaire per trial was selected in 116 or 27,1% of the studies. The most 
frequently used questionnaires were the Beck Depression Inventory BDI (Beck 
et al. 1961), Block Food Frequency questionnaire (Block and Subar, 1992) and 
Three-Factor Eating Questionnaire TFEQ (Stunkard and Wadden, 1992) with 
a prevalence of 5,8% (n= 25 studies), 3,5% (n= 15 studies) and 3,5% (n= 15 
studies), respectively.  
Most often used clinical and physiological outcome measures referred to 
nutritional parameters (i.e. caloric intake (fat/protein/carbohydrate), eating 
habits), body measurements (i.e. BMI, weight, waist circumference, bodily fat 
distribution) cardiovascular parameters (i.e. heart rate, blood pressure, 
exercise tests), laboratory parameters (i.e. cholesterol, triglyceride, HDL, LDL, 
 23
Results 
 
fatty acids, glucose, insulin, thyroid function, metabolic rate), lung function (i.e. 
FEV1, FVC, peak expiratory flow rate, lung volumina parameters, ventilation 
rate, oxygen consumption/uptake, carbon dioxide production, respiratory 
quotient) as well as physical activity, sleep, fatigue and pain. Also patient 
compliance and adverse events were frequently reported study outcomes. 
 
5.3 Step 3: Linkage of the Concepts 
In step 3, a total of 16034 concepts and goals were extracted. 12914 
concepts/goals (81%) could be linked to the ICF, 527 concepts/goals (3%) 
were considered not to be sufficiently specified for an assignment to the ICF, 
and 2593 concepts (16%) were considered to be not covered by the ICF. 
“Weight” that with 75% was the most frequent concept is a personal factor that 
could not be linked to the ICF, since personal factors are not classified yet. 
The 12914 assignable concepts/goals contained in the outcome measures 
were linked to 360 different ICF categories at the second, third, and fourth 
levels of the classification. 169 ICF categories belonged to the ICF component 
‘Body Functions’, 55 belonged to the component Body Structures, 115 to 
component Activities and Participation, and 21 to the component 
Environmental Factors.  
The concepts contained in the outcome measures were linked to 173 different 
second-level ICF categories, also including the more specific third-, and fourth- 
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level categories. Of these second-level ICF categories 20 reached a frequency 
of at least 10% (14 body functions, 1 body structure, 4 activities and 
participation, 1 environmental factor). Most frequently measured body 
functions were b540 general metabolic functions (65 %), b420 blood pressure 
functions (39 %), and b410 heart functions (39 %). Within the ICF component 
activities and participation the category d570 looking after one’s health (57 %) 
showed the highest relative frequencies. For the components environmental 
factors and body structures only the category e110 products or substances for 
personal consumption (16 %) and s760 structure of the trunk (13%) presented 
a relative frequency above 10%, respectively.  
 Tables 3 and 4 show the ICF categories that were linked to the 
concepts/goals contained in the different outcome measures of the studies. 
Both the frequencies and percentages of the 2nd-level categories taking into 
account that the 3rd and 4th level categories belong to the 2nd level, as well as 
the frequencies and percentages of the ICF categories from the 2nd to the 4th 
level are presented. Only ICF categories with a percentage >10% at the 2nd 
level of the classification are shown. 
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6. Discussion 
 
Using the ICF as a reference, it was possible to identify and quantify the 
concepts within the outcome measures used in RCTs for interventions in 
obese patients. Most concepts in the outcome measures could be linked to the 
ICF. Those which could not be linked were mostly not covered by the ICF. In 
these cases, the content of the concepts did not lie within the defined contents 
of the ICF. This was most often the case for adverse events. Furthermore, 
outcome measures on health status containing dimensions like personal 
factors are not covered by the current ICF and could therefore not be linked. 
Concepts referring to personal factors included “weight”, ”habit”, or ”attitudes 
towards oneself” or concepts on patient satisfaction (“How satisfied are you 
with …”). Only a small number of concepts were not specified in enough detail 
for an assignment. 
Most ICF categories that represent the outcomes measures used in 
RCTs from 1992 to 2001 selected for this review belong to the component 
Body Functions. The low number of categories from the component Activities 
and Participation is consistent with the low use of health-status instruments 
which typically represent activities and participation (Stucki 2003).  
Most of the ICF categories with relative frequencies above 10% in the 
component Body Functions represent areas of functioning that are in line with 
the well-known major dangers of obesity, such as hypertension, dyslipidemia,  
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coronary-artery disease, sleep apnoea, or respiratory problems (Pi-Sunyer 
1993). Endocrine gland functions are also represented in a high number of 
studies because intestinal hormones are an important area in obesity research 
(Batterham 2003). The category haematological system functions were 
selected to link the important marker HbA1C. 
Specific mental functions within the ICF category b130 energy and drive 
functions were addressed in many studies. This reflects the well-known 
association between obesity and functions like energy level, motivation, 
appetite, craving and impulse control (Simansky 2005,  van Hout 2004). 
Sleep problems are also clearly associated with obesity (Grimm 2006, 
Lamberg 2006, Namyslowski 2005). Sleep deprivation has even been 
hypothesised to contribute toward obesity by decreasing leptin, increasing 
ghrelin, and compromising insulin sensitivity (Gangwisch 2005). Therefore, it is 
not surprising that all third-level categories contained in the second-level 
category sleep functions have also been taken into account in 17% of the 
investigations included in this review. Quality of sleep was the area most 
frequently investigated (Gupta 2002). 
Emotional Functions are represented in 21% of the studies. This may 
reflect the fact that the question whether or not mood disorders and obesity 
are related has been a focus of scientific investigation and debate for at least 
the last 50 years. Since the available literature has not provided a definitive 
answer to that question yet, the study of this relationship will probably continue 
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to be an objective in clinical investigation in the years to come (McElroy 2004).  
The category sensation of pain was an outcome in only 13% of the 
studies. Based on the fact that pain is considered as an independent 
contributor to impaired HRQL in obesity (Barofsky 1998), the author expected 
a higher number of studies including this outcome. It is interesting to note that 
not only generalized pain, but also localized pain in many different body 
locations was taken into account. 
Limitations and restrictions in Activities and Participation are, indeed, of 
great relevance to obese patients (Stucki 2004). The areas with relative 
frequencies above 10% represent key issues for obese patients, including 
walking and looking after one’s health. The latter includes managing diet and 
fitness and maintaining one’s health at the third level of the classification. The 
ICF category managing diet and fitness was considered in almost half of the 
investigations. This reflects the fact that behavioral modification in obesity is 
not only relevant after psychological interventions, but also after treatments 
like surgery and that the effectiveness of any intervention has to be measured 
based not only as weight reduction, but also as behavioral modification at the 
level of maintaining diet and fitness. 
It is important to note that the category d550 eating within the 
component Activities and Participation refers according to the ICF definition to 
“carrying out the coordinated tasks and actions of eating food that has been  
 
 28
Discussion 
 
served, bringing it to the mouth and consuming it in culturally acceptable ways, 
cutting or breaking food into pieces, opening bottles and cans, using eating 
implements, having meals, feasting or dining.” The study outcomes assessing 
to what extent the activity of eating are performed in a socially proper way was 
linked to this ICF category. This was especially the case in studies with a study 
population with binge eating disorder, which represent nearly 35% of the 
clinically obese population (Marcus 1995). 
Discrimination at work, in public, and interpersonally is common 
(Stunkard 1992, Rand 1990, Klesges 1990) in obese persons. Obese persons 
are often regarded as “dirty” ,”lazy”, “stupid”, “cheating”, “lying”, and “ugly” 
(Kushner 2000). The influence such attitudes take on the involvement in life 
situations of individuals, such as at work, in interpersonal interactions, and in 
social and recreational life is well-known (Chambliss 2004). Therefore, the fact 
that only the ICF category recreation and leisure was addressed as an 
outcome is quite remarkable. Further categories, such as remunerative 
employment and family relationships seem to be missing. 
It is surprising that, although obesity is currently understood to be a 
complex condition with many interactions, especially between gene and 
environment (Thigpen 2004), only the ICF category e110 products or 
substances for personal consumption, which includes at the third level of the 
classification e1100 food, was reported as an outcome measured in the 
studies considered in this review. 
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The category structure of trunk (s760) is represented in 13% of the 
studies because it was considered the most specific ICF category to address 
the outcome waist circumference.  
The results of this literature review can provide a preliminary basis for 
the definition of domains regarding “what should be measured” to 
comprehensively describe the burden of obesity and/or the evaluation of 
treatment outcomes. Nevertheless, it is important to put the results and their 
interpretation into perspective. 
The outcomes measures used in the studies influence the spectrum and 
the frequency of concepts linked to the ICF categories and consequently the 
results of this study. The choice of the outcomes measures may depend on 
the intervention and the subset of patients studied. In addition, the majority of 
studies were drug trials focusing on clinically relevant parameters and not 
functioning. 
Although it is beyond the scope of this paper to discuss whether the 
outcome measures used and the concepts linked to the ICF in this study are 
appropriate for specific study questions and whether or not they adequately 
represent the patient experience, these findings reflect drug trials apparently 
fail to assess the importance of patients’ functioning and the influence of 
environmental factors on it. In different clinical fields there is growing evidence 
that correlations between clinical measures and how patients feel and how  
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they are able to function in daily activities are only weak to moderate 
(Bendtsen 2003, Juniper 2002, Moy 2001, Juniper 1995). Outcome research  
has shown that through the assessment of functioning and HRQL, in addition 
to physiological parameters, it is more likely to develop interventions that do 
not simply correct physiological abnormalities, but truly improve health 
(Conners 2002).  
There exist many obesity-specific health-status measures (Wadden 
2002). A recently published study, in presenting a content comparison of all 
obesity-specific health-status measures based on the ICF demonstrated that 
most of these instruments cover a wide spectrum of activities and areas of 
participation (Stucki 2006). Some of these instruments have been 
recommended by international organizations, such as the North American 
Association for the Study of Obesity (NAASO). If these recommendations are 
put into practice, a review similar to this one, but containing a greater number 
of outcome measures addressing ICF categories within the component 
activities and participation, could be available five years from now. 
It is important to emphasise that the results presented in this paper 
exclusively provide information about the frequency of use of determined 
questionnaires. However, frequency of use does not automatically imply 
quality regarding the psychometric properties of a determined instrument. 
Therefore, the results of this review should not be used as a basis for the 
selection of instruments to be included in a concrete study. The first question  
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when selecting instruments is to decide what should be measured in 
consideration of the study endpoints, the population studied, and the 
intervention. The second question is to decide which instrument to use 
amongst all the possible instruments available. For information about the 
concepts addressed by different instruments, we refer readers to the paper by 
Stucki et al. However, further considerations, such as practicability and length 
of the instrument, response categories and psychometric characteristics are 
also indispensable. 
Our findings do not constitute a recommendation for a minimal set of 
measuring instruments covering relevant ICF categories. However, if enough 
care is consistently taken in RCTs to define ”what should be measured” to 
ensure a more comprehensive and comparable comparison of persons with 
obesity across studies and interventions, a reliable recommendation could be 
presented regarding what instruments to use. 
Within this context, the project to develop ICF Core Sets for persons 
with different health conditions, including obesity, that is being performed in 
collaboration between the ICF Research Branch of WHO FIC CC (DIMDI) at 
the Department of Physical Medicine and Rehabilitation of the Ludwig-
Maximilian University in Munich (http:\\www.ICF-Research-Branch.org) and 
WHO deserves mention (Stucki 2002, Stucki 2004, Cieza 2004). An ICF Core 
Set represents a minimal number of categories necessary to accurately reflect 
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functioning (Stucki 2002) for the particular health condition. Therefore, the so-
called Brief ICF Core Set for obesity can serve as reference for 
recommendations concerning instruments to be used in studies involving 
obese patients in the future. 
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7. Conclusion 
The ICF provides a useful reference to identify and quantify the 
concepts within the outcome measures used in RCTs for obesity. The need 
exists to systematically include patient-oriented measures to address areas of 
the ICF component activities and participation that are extremely relevant to 
obese persons. 
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Table 1: Inclusion/exclusion criteria for the randomized clinical trials  
Inclusion criteria Exclusion criteria 
Study population with obesity  Randomised n of 1 study (Synonym: 
“n=1" –trial) 
Randomised Controlled Trial (RCT)  Partial randomisation 
Prospective design Clinical controlled trial (CCT)  
Design with parallel groups, cross-
over, or waiting list 
Uncontrolled experimental study 
Therapeutic intervention Cross-sectional study  
All intervention types Longitudinal observational cohort 
study  
English publication Psychometric study 
Journal with the highest impact factor 
in the case of multiple publications 
Primary prevention study (healthy 
study population) 
 Animal experiment 
 Laboratory study 
 Cadaver study 
 Letter 
 Comment 
 Editorial 
 Non-therapeutic intervention 
 Mixed population 
 Children and adolescents 
 Coronary heart disease 
 Stroke 
 Osteoarthritis 
 Diabetes Type I and II 
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Table 2: Questionnaires that were used in more than 2 studies, the number of 
studies in which they were used and type of instrument 
 
Questionnaire N Type 
Beck Depression Inventory BDI  25 DS 
Block Food Frequency Questionnaire 15 DS* 
Three-Factor Eating Questionnaire TFEQ 15 EDS 
Binge Eating Scale - Eating Habits Checklist Gormally 14 EDS 
Paffenbarger Physical Activity Index 12 DS 
Short Form Health Survey SF-36 7 G 
State-Trait-Anxiety-Inventory STAI 7 DS 
Centre for Epidemiologic Studies – Depression Scale CES-D 6 DS 
Restraint Scale - Herman & Polivy 5 EDS 
Rosenberg Self-Esteem Scale RSE 5 DS 
Fibromyalgia Impact Questionnaire FIQ 5 CS (Fibromyalgia) 
Arthritis Impact Measurement Scale AIMS 3 CS (rheumatoid arthritis) 
Eating Disorders Inventory EDI 3 EDS 
Hospital Anxiety and Depression Scale HADS 3 DS 
Maudsley Obsessional-Compulsive Inventory MOCI 3 CS (compulsive disorders) 
General Internal-External Expectancy Locus of Control Scale I-E 
Scale 
2 DS 
Sickness Impact Profile SIP 2 G 
Symptom Checklist 90 - SCL 90 2 CS (psychological problems and 
symptoms of psychopathology) 
Arthritis Self-Efficacy Scale ASES 2 CS (rheumatoid arthritis) 
Body Cathexis Scale 2 DS 
Bulimic Investigatory Test Edinburgh BITE 2 EDS 
Dutch Eating Behavior Questionnaire DEBQ 2 EDS 
Eating Disorder Examination EDE 2 EDS 
Food Preference Checklist – FPC 2 DS* 
Hamilton Rating Scale of Depression 2 DS 
Impact of Weight on Quality of Life Questionnaire IWQOL 2 EDS 
 
 
CS: Condition specific; DS: Dimension specific; EDS: Eating disorder specific; G: 
Generic; OS: Obesity specific 
* These instruments address food consumption behaviors and food handling 
practices and can be used in the general population. Therefore, they are considered 
dimension specific. 
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Table 3: ICF categories of the components body functions and structures that 
were linked to the concepts contained in the outcome measures. The 3rd and 
4th columns refer to the frequencies and percentages of the 2nd- level 
categories taking into account that the 3rd and 4th level categories belong to the 
2nd level. The 5th and 6th columns refer to the frequencies and percentages of 
the ICF categories from the 2nd to the 4th level. Only ICF categories with a 
percentage >10% at the 2nd level of the classification are presented. 
 
 
 
ICF CODE Title N % 
(n=428) 
N % (n=428) 
Body Functions 
b130 Energy and drive functions 90 21 18 4 
b1300 Energy level    65 15 
b1301 Motivation    6 1 
b1302 Appetite    49 11 
b1303 Craving    30 7 
b1304 Impulse control   32 8 
b134 Sleep functions 73 17 16 4 
b1340 Amount of sleep    11 3 
b1341 Onset of sleep    17 4 
b1342 Maintenance of sleep    23 5 
b1343 Quality of sleep    43 10 
b1344 Functions involving the sleep cycle    8 2 
b152 Emotional functions 90 21 94 22 
b1520 Appropriateness of emotion    4 1 
b1521 Regulation of emotion    8 2 
b1522 Range of emotion    70 16 
b160 Thought functions 56 13 6 1 
b1600 Pace of thought    2 1 
b1602 Content of thought    50 12 
b1603 Control of thought    21 5 
b280 Sensation of pain 56 13 34 8 
b2800 Generalized pain    3 1 
b2801 Pain in body part    4 1 
b28010 Pain in head and neck    16 4 
b28011 Pain in chest   5 1 
b28012 Pain in stomach or abdomen   5 1 
b28013 Pain in back   11 3 
b28016 Pain in joints   11 3 
b2802 Pain in multiple body parts    2 1 
b410 Heart functions 120 28 33 8 
b4100 Heart rate    100 23 
b4101 Heart rhythm    1 0 
b4102 Contraction force of ventricular muscles    8 2 
b420 Blood pressure functions 167 39 166 39 
b4200 Increased blood pressure    3 1 
b430 Haematological system functions 51 12 28 7 
b4301 Oxygen-carrying functions of the blood    9 2 
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b4302 Metabolite-carrying functions of the blood    1 0 
b4303 Clotting functions    28 7 
b440 Respiration functions 47 11 17 4 
b4401 Respiratory rhythm    4 1 
b4402 Depth of respiration    30 7 
b455 Exercise tolerance functions 90 21 22 5 
b4550 General physical endurance    16 4 
b4551 Aerobic capacity    69 16 
b4552 Fatiguability    4 1 
b530 Weight maintenance functions 60 14 58 14 
b540 General metabolic functions 278 65 76 18 
b5400 Basal metabolic rate    77 18 
b545 Water, mineral and electrolyte balance functions 77 18 1 0 
b5450 Water balance    1 0 
b5451 Mineral balance    58 14 
b5452 Electrolyte balance    49 11 
b555 Endocrine gland functions 94 22 95 22 
Body Structures 
s760 Structure of trunk 56 13 50 12 
s7600 Structure of vertebral column    3 1 
s76002 Lumbar vertebral column    3 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38
Tables 
 
Table 4: ICF categories of the components activities and participation and 
environmental factors that were linked to the concepts contained in the 
outcome measures. The 3rd and 4th columns refer to the frequencies and 
percentages of the 2nd- level categories taking into account that the 3rd and 
4th level categories belong to the 2nd level. The 5th and 6th columns refer to 
the frequencies and percentages of the ICF categories from the 2nd to the 4th 
level. Only ICF categories with a percentage >10% at the 2nd level of the 
classification are presented. 
 
ICF CODE Title N % 
(n=428) 
N % 
(n=428)
Activities and Participation 
d450 Walking 43 10 30 7 
d4500 Walking short distances    16 4 
d4501 Walking long distances    15 4 
d4502 Walking on different surfaces    4 1 
d550 Eating 43 10 44 10 
d570 Looking after one’s health 244 57 18 4 
d5701 Managing diet and fitness    211 49 
d5702 Maintaining one's health    94 22 
d920 Recreation and leisure 56 13 41 10 
d9201 Sports   19 4 
d9202 Arts and culture   1 0 
d9204 Hobbies   4 1 
d9205 Socializing   25 6 
Environmental Factors 
e110 Products or substances for personal consumption 68 16 20 5 
e1100 Food   54 13 
e1101 Drugs   15 4 
 
 
 
 
 
 
 
 
 
 
 
 39
References 
 
8. References 
 
1. Abelson P, Kennedy D. The obesity epidemic. Science. 2004 Jun 4;
 304(5676):1413. 
2. Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: 
assessment and clinical implications. Obes Res. 2002 Nov; 10 Suppl 
1:14S-21S. 
3. Barofsky I, Fontaine KR, Cheskin LJ. Pain in the obese: impact on 
health-related quality-of-life. Ann Behav Med 1998; 19: 408-410. 
4. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, 
et al. Inhibition of Food Intake in Obese Subjects by Peptide YY3-36. N 
Engl J Med 2003; 349): 941-948. 
5. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring 
depression. Arch Gen Psych 1961;4:561-571. 
6. Bendtsen P, Leijon M, Sommer AS, Kristenson M. Measuring health-
related quality of life in patients with chronic obstructive pulmonary 
disease in a routine hospital setting: feasibility and perceived value. 
Health quality of life outcomes 2003;1:5-13. 
7. Block G, Subar AF. Estimates of nutrient intake from a food frequency 
questionnaire: The 1987 National Health Interview Survey. J Am Diet 
Assoc 1992;92:969-977. 
 
 40
References 
 
8. Boers M, Tugwell P, Felson DT, Van Riel PL, Kirwan JR, Edmonds JP et 
al. World Health Organization and international league of associations 
for rheumatology core endpoints for symptom modifying antirheumatic 
drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994;41:86-9. 
9. Bowling A. Measuring disease. A review of disease-specific quality of life 
measurement scales. Buckingham: Open University Press, 1995. 
10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, 
obesity, and mortality from cancer in a prospectively studied cohort of 
U.S. adults. N Engl J Med. 2003 Apr 24;348(17):1625-38. 
11. Chambliss HO, Finley CE, Blair SN. Attitudes toward obese individuals 
among exercise science students. Med Sci Sports Exerc. 
2004;36(3):468-474. 
12. Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Stucki G. Linking 
Health-Status Instruments to the ICF. J Rehabil Med 2002; 34(5): 205-
210. 
13. Cieza A, Ewert T, Üstün TB, Chatterji S, Kostanjsek N, Stucki G. 
Development of ICF Core Sets for patients with chronic conditions. J 
Rehab Med 2004; Suppl. 44:9-11. 
14. Colditz G. Economic costs of obesity and inactivity. Medicine and 
Science in Sport and Exercise 1999, 31 (suppl 11): S663-S667. 
15. Conners Jr. AF. The transformation oft medicine: The role of outcomes 
research. Obes Res 2002;10,Suppl. 1:3S-5S. 
 41
References 
 
16. Curtis LG. Join the battle against obesity. JAAPA. 2004 Apr; 17(4):9-10,  
17. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for 
systematic reviews. BMJ 1994; 309: 1286-1291. 
18. Fine, J. T., G. A. Colditz, et al. (1999). A prospective study of weight 
change and health-related quality of life in women. Jama 282(22): 2136-
42. 
19. Flegal KM, Graubard BI, Williamson DF. Methods of calculating deaths 
attributable to obesity. Am J  Epidemiol. 2004 Aug 15;160(4):331-8. 
20. Fontaine, K. R., L. J. Cheskin, et al. (1996). Health-related quality of life 
in obese persons seeking treatment. J Fam Pract 43(3): 265-70. 
21. Freedman, D. S., L. K. Khan, et al. (2002). Trends and correlates of 
class 3 obesity in the United States from 1990 through 2000. Jama 
288(14): 1758-61. 
22. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. 
Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. 
Sleep. 2005;28(10):1289-96. 
23. Grimm W, Becker HF. Obesity, Sleep Apnea Syndrome, and 
Rhythmogenic Risk. Herz. 2006;31(3):213-218. 
24. Gupta NK, Mueller WH, Chan W, Meininger JC. Is obesity associated 
with poor sleep quality in adolescents? Am J Hum Biol. 2002;14(6):762-
8. 
 
 42
References 
 
25. Gyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. 
Annals of Internal Medicine 1993; 15(118): 622-629  
26. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja 
A. Quality of life in asthma clinical trials: comparison of salmeterol and 
salbutamol. Am J Respir Crit Care Med 1995;151:66-70. 
27. Juniper EF, Price DB, Stampone PA, Creemers JPHM, Mol SJM, 
Fireman P. Clinically important improvements in asthma-specific quality 
of life, but no difference in conventional clinical indexes in patients 
changed from conventional beclomethasone dipropionate to 
approximately half the dose of extrafine beclomethasone dipropionate. 
Chest 2002;121:1824-1832. 
28. Klesges RC, Klem M, Hanson CL, Eck LH, O’Laughlin D, Garrott A, Rife 
R. The effects of applicant’s health status and qualifications on 
simulated hiring decisions. Int J Obes 1990;14:527-535. 
29. Kolotkin, R.L., Head S., Brookhart A., (1997) Construct validity of the 
Impact of Weight on Quality of Life Questionnaire. Obes Res 5: 434-441 
30. Kushner RF, Foster GD. Obesity and Quality of Life. Nutrition 
2000;16:947-952. 
31. Lamberg L. Rx for obesity: eat less, exercise more, and--maybe--get 
more sleep. JAMA. 2006; 24;295(20):2341-4. 
 
 
 43
References 
 
32. Larsson, U., J. Karlsson, et al. (2002). Impact of overweight and obesity 
on health-related quality of life--a Swedish population study. Int J Obes 
Relat Metab Disord 26(3): 417-24. 
33. Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its 
high toll. JAMA. 2003 Jan 8;289(2):229-30. 
34. Manson JE, Skerrett PS, Willett WC. Obesity as a risk factor for major 
health outcomes. In: Bray GA, Bouchard C, eds. Handbook of Obesity. 
New York, NY: Marcel Dekker Inc. 2004. 
35. Marcus M. Binge Eating and Obesity. In: Brownell K, Fairburn C, editors. 
Eating Disorder and Obesity. New York / London: Guilford Press; 1995. 
36. Mathus-Vliegen EM, de Weerd S, de Wit LT. Health-related quality-of-
life in patients with morbid obesity after gastric banding for surgically 
induced weight loss. Surgery. 2004 May;135(5):489-97. 
37. McDowell I, CN. Measuring Health. A Guide to Rating Scales and 
Questionnaires. 2nd edition ed. New York: Oxford University Press; 
1996 
38. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. 
Are mood disorders and obesity related? A review for the mental health 
professional. J Clin Psychiatry. 2004 May;65(5):634-651. 
39. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of 
death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45. 
 
 44
References 
 
40. Moy ML, Israel E, Weiss ST, Juniper EF, Dubé L, Drazen JM and the 
NHLBI Asthma Clinical Research Network. Clinical predictors of health-
related quality of life depend on asthma severity. Am J Respir Crit Care 
Med 2001;163:924-929. 
41. Namyslowski G, Scierski W, Mrowka-Kata K, Kawecka I, Kawecki D, 
Czecior E. Sleep study in patients with overweight and obesity. J Physiol 
Pharmacol. 2005; 56 Suppl 6:59-65. 
42. National Institute of Health. The Practical Guide: Identification, 
Evaluation, and Treatment of Overweight and Obesity in Adults. 
Publication number 00-4084. National Institute of Health: October 2000. 
43. Ogden, C. L., K. M. Flegal, et al. (2002). Prevalence and trends in 
overweight among US children and adolescents, 1999-2000. Jama 
288(14): 1728-32. 
44. Peeters A, Bonneux L, Nusselder WJ, De Laet C, Barendregt JJ. Adult 
obesity and the burden of disability throughout life. Obes Res. 2004 
Jul;12(7):1145-51. 
45. Pi-Sunyer, F. X. (1993). Medical hazards of obesity. Ann Intern Med 
119(7 Pt 2): 655-60. 
46. Rand CS, Macgregor AMC. Morbidly obese patients’ perceptions of 
social discrimination before and after surgery for obesity. South Med J 
1990;83:1390-1395. 
 
 45
References 
 
47. Seidell, J. C. (1995). The impact of obesity on health status: some 
implications for health care costs. Int J Obes Relat Metab Disord 19 
Suppl 6: S13-6. 
48. Simansky KJ. NIH symposium series: ingestive mechanisms in obesity, 
substance abuse and mental disorders. Physiol Behav. 2005;86(1-2):1-
4. 
49. Stucki A, Daansen Pr, Fuessl M, Cieza A, Huber E, Atkinson R, 
Kostanjsek N, Stucki Gerold, Ruof J.  ICF Core Sets for Obesity. Journal 
Rehabilitation Medicine 2004;2:107-113. 
50. Stucki A, Borchers M, Stucki G, Cieza A, Amann E, Ruof J. Content 
comparison of health status measures for obesity based on the 
international classification of functioning, disability and health. Int J 
Obes. 2006; 4; [Epub ahead of print] 
51. Stucki G, Cieza A, Ewert T, Konstanjsek N, Chatterji S, Bedirhan Ustun 
T. Application on the international classification of functioning, disability 
and health (ICF) in clinical practice. Disabil Rehabil 2002; 24(5):281-
282. 
52. Stucki G, Ewert T, Cieza A. Value and application of the ICF in 
rehabilitation medicine. Disability Rehabilitation 2002; 24(17): 932-938 
53. Stucki G, Ewert T, Cieza A. Value and application of the ICF in 
rehabilitation medicine. Disabil Rehabil. 2003;25 (11-12):628-34. 
 
 46
References 
 
54. Stucki G. Understanding disability. Annals Rheum Dis 2003;62(4):289-
90. 
55. Stucki G, Grimby G. Foreword: Applying the ICF in medicine.  J Rehab 
Med 2004; Suppl. 44:5-6. 
56. Stunkard AJ, Messick S. The three-factor eating questionnaire to 
measure dietary restraint, disinhibition and hunger. J Psychosom Res 
1985;29:71-83. 
57. Stunkard AJ, Wadden TA. Psychological aspects of severe obesity. Am 
J Clin Nutr 1992;55:524S-532S. 
58. Task Force on Developing Obesity Outcomes and Learning Standards 
(TOOLS). Summary of Outcome Measures. Obes Res 2002 10(Suppl 
1): 76S-78S.  
59. Thigpen KG. Fighting obesity through the built environment. Environ 
Health Perspect. 2004;112(11):616-619. 
60. van Hout GC, van Oudheusden I, van Heck GL. Psychological profile of 
the morbidly obese. Obes Surg. 2004;14(5):579-88. 
61. Wadden TA, Phelan S. Assessment of quality of life in obese individuals. 
Obes Res. 2002;10 Suppl 1:50S-57S. 
62. WHO (2002). World health report 2002: reducing risks, promoting 
healthy life. Geneva, World Health Organization; 2002. 
63. WHO, International Classification of Functioning, Disability and Health: 
ICF, Ist edn. Geneva: WHO, 2001, Available at 
www.3.who.int./icf/icftemplate.cfm (accessed 25 May 2004) 
 47
References 
 
64. Wolf AM. Introduction: Task Force on Developing Obesity Outcomes 
and Learning Standards (TOOLS). Obes Res 2002; 10 Suppl 1: 1S-2S. 
65. Wolf, A. M. (2002). Economic outcomes of the obese patient. Obes Res 
10 Suppl 1: 58S-62S. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48
Attachment 
 
9. Attachment (Anhang) 
 
 9.1 ICF- Definitions: 
 
Body functions are the physiological functions of body systems (including 
psychological functions). 
 
Body structures are the anatomical parts of the boy such as organs, limbs 
and their components. 
 
Impairments are problems in body function or structure such as significant 
deviation or loss. 
 
Activity is the execution of a task or action by an individual. 
 
Participation is involvement in a live situation. 
 
Activity limitations are difficulties an individual may have in executing 
activities. 
 
Participation restrictions are problems an individual may experience in 
involvement in life situations. 
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Environmental factors make up the physical, social and attitudinal 
environment in which people live and conduct their lives. 
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Pullach  
5 Monate im Kinderzentrum 
München  
bei Prof. Dr. med. Dr. h.c. H. von 
Voß 
 
Hochschulausbildung 
 
Studium   WS 1998/99 Humanmedizin an der  
- SS 2005 Ludwig-Maximilians-Universität 
München 
 
Famulaturen  2001   Allgemeinmedizin in der Praxis  
Dr. med. R. Galmbacher; 
Klingenberg 
2002  Innere Medizin im Samui 
International Hospital; Koh Samui / 
Thailand 
2003  Orthopädie im Klinikum 
Grosshadern  
2003 Ästhetische Chirurgie in einer 
Münchner Privatklinik  (Clinica 
Medico GmbH Kufsteiner Platz 4) 
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Hospitationen  08/2003  Universitätsklinik Innsbruck 
Abteilung Plastische Chirurgie  
bei Prof. Dr. med. H. Pizza 
02/2005  Klinikum Bogenhausen  
Abteilung Plastische Chirurgie  
bei Prof. Dr. med. M. Ninkovic 
    03/2005  Marienhospital Stuttgart 
       Abteilung Plastische Chirurgie 
       bei Prof. Dr. med. M. Greulich 
       bei Prof. Dr. med. W. Gubisch 
    05/2005  Universitätsklinikum Leipzig 
Klinik und Poliklinik für Mund-, 
Kiefer- und Plastische 
Gesichtschirurgie   
       bei Prof. Dr. Dr. A. Hemprich 
    05/2005  Universitätsklinikum Tübingen 
Klinik und Poliklinik für Mund-, 
Kiefer und Gesichtschirurgie 
bei Prof. Dr. Dr. Reinert 
 
Praktisches Jahr  1. Tertial  Chirurgie im Klinikum Großhadern, 
bei Prof. Dr. med. K.-W. Jauch  
2 Monate Unfallchirurgie  
bei Dr. med. S. Piltz  
2 Monate Plastische Chirurgie und 
Handchirurgie 
bei Prof. Dr. med. R. G. H. 
Baumeister 
 
2. Tertial Psychiatrie an der Psychiatrischen 
Klinik der Ludwig-Maximilians-
Universität  
bei Prof. Dr. med.  H.-J. Möller 
 
3. Tertial Innere Medizin im 
Kreiskrankenhaus Starnberg  
bei Prof. Dr. med. P. Trenkwalder 
 
Ärztliche Prüfung     09.05.2005 
 
       Wissenschaftliche Tätigkeit 
 
Dissertation  Thema: “Identifying the concepts 
contained in outcome measures of  
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clinical trials on obesity using the 
international classification of 
functioning, disability and health as 
a reference” aus der Klinik und 
Poliklinik für Physikalische Medizin 
der Ludwig-Maximilians-Universität 
München bei Herrn Prof. Dr. med. 
G. Stucki 
 
  
 
Besondere Kenntnisse / 
Interessen    
 
Sprachen      Englisch     
       Französisch 
 
Hobbys  Klavier  
 Tennis 
  Mitglied im Deutschen Alpenverein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
